AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Clinical High Risk

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer NCT05998135Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: Atovaquone, Biopsy, Computed Tomography, Paracentesis PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachytheโ€ฆ A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter NCT07116525NA5 sites๐Ÿ“ Bruges๐Ÿ“ Hasselt๐Ÿ“ Pessac Biosense Webster, Inc. ยท Tests: Paddle-Shaped, High-Density, Multi-Electrode Mapping Catheter Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma NCT06588205n/a20 sites๐Ÿ“ Alessandria๐Ÿ“ Ancona๐Ÿ“ Bari Fondazione Italiana Linfomi - ETS Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients NCT06918834Phase 25 sites๐Ÿ“ Beijin๐Ÿ“ Zhengzhou๐Ÿ“ Jinan Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Immediate HSCT Group, Bridging Therapy Group R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden NCT05040555NA1 site๐Ÿ“ Changchun oubai, MD/PhD ยท Tests: R-CDOP Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks NCT05212454Phase 31 site๐Ÿ“ Hanzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Capecitabine A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites๐Ÿ“ Bakersfield๐Ÿ“ New Brunswick๐Ÿ“ Myrtle Beach Merck Sharp & Dohme LLC ยท Tests: MK-3120 Vienna HIV Infection Via Sex Study NCT05326061n/a1 site๐Ÿ“ Vienna Medical University of Vienna Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions NCT06658405Phase 21 site๐Ÿ“ Lille Centre Oscar Lambret ยท Tests: Human Papillomavirus 9-valent Vaccine, Recombinant Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod NCT06356012Phase 41 site๐Ÿ“ Barretos Barretos Cancer Hospital ยท Tests: Imiquimod, Loop Electrosurgical Excision Procedure Culturally Adapted Dietary Clinical Trial in PR NCT05962372NA1 site๐Ÿ“ San Juan Harvard School of Public Health (HSPH) ยท Tests: Culturally tailored food and diet advice, Standard healthy eating advice Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas NCT06687681Phase 21 site๐Ÿ“ Tehran Marzieh Ebrahimi ยท Tests: NK cell therapy Antenatal Magnesium Sulphate in High-Risk Preterm Patients NCT07524972Phase 31 site๐Ÿ“ Ismailia Cairo University ยท Tests: Magnesium sulfate, Placebo CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors NCT06365671Phase 21 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer NCT07646145Phase 21 site๐Ÿ“ Taiyuan Shanxi Province Cancer Hospital ยท Tests: Disitamab Vedotin, Mitomycin C (MMC) Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU NCT05500118n/a1 site๐Ÿ“ Shenzhen Shenzhen Maternity & Child Healthcare Hospital ยท Tests: Patients Decision Aids Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer NCT07125391Phase 21 site๐Ÿ“ Hefei Bai-Rong Xia ยท Tests: Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients NCT04025450Phase 1, Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Chidamide+VRD, VRD Adebrelimab and Chemoradiotherapy in High-risk LANPC NCT06349889Phase 24 sites๐Ÿ“ Xiamen๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Adebrelimab A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Hemodynamic Optimization Using an Artificial Intelligenze System NCT07366164NA1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: assisted fluid therapy A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis NCT07551427Phase 224 sites๐Ÿ“ Hefei๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQ05105 Tablets (Rovadicitinib Tablets) Comparisons Of Biochemical And Clinical Outcomes Of Hemodialysis Patients Treated With Middle Cut-Off Dialyzers Versus High-Flux Hemodialysis Or Hemodiafiltration NCT07561424n/a1 site๐Ÿ“ Paris Arbor Research Collaborative for Health The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy NCT06388720Phase 21 site๐Ÿ“ Goyang-si National Cancer Center, Korea ยท Tests: Mitomycin-C, gemcitabine Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM NCT07109323Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: BCMA CART HFNC vs NIPPV Following Extubation NCT05869825NA1 site๐Ÿ“ Atlanta Emory University ยท Tests: High Flow Nasal Canula following extubation, Non-Invasive Positive Pressure Ventilation following extubation GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. NCT06851247Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Toripalimab, Anlotinib, Gemcitabine, Cisplatin, radiation Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence NCT06644937Phase 2, Phase 31 site๐Ÿ“ Guangzhou Zhujiang Hospital ยท Tests: TACE combined with Acoradine Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score NCT07490067Phase 41 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: Metoprolol Succinate, Beta-Blocker Polygenic Score, Illumina Infinium Global Diversity Array with Enhanced Pharmacogenoโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy